Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance
Asparaginase is one of the most important chemotherapeutic agents against pediatric acute lymphoblastic leukemia (ALL), the most common form of childhood cancer. The therapeutic efficacy (e.g., chemoresistance) and adverse effects of asparaginase (e.g., hypersensivity and pancreatitis) have been inv...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2015-10-01
|
| Series: | Pediatrics and Neonatology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1875957214001983 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850229973647884288 |
|---|---|
| author | Shih-Hsiang Chen |
| author_facet | Shih-Hsiang Chen |
| author_sort | Shih-Hsiang Chen |
| collection | DOAJ |
| description | Asparaginase is one of the most important chemotherapeutic agents against pediatric acute lymphoblastic leukemia (ALL), the most common form of childhood cancer. The therapeutic efficacy (e.g., chemoresistance) and adverse effects of asparaginase (e.g., hypersensivity and pancreatitis) have been investigated over the past four decades. It was suggested early on that leukemic cells are resistant to asparaginase because of their increased asparagine synthetase activity. Afterward, other mechanisms associated with asparaginase resistance were reported. Not only leukemic cells but also patients themselves may play a role in causing asparaginase resistance, which has been associated with unfavorable outcome in children with ALL. This article will briefly review asparaginase therapy in children with ALL and comprehensively analyze recent reports on the potential mechanisms of asparaginase resistance. |
| format | Article |
| id | doaj-art-d73f16eced3145af9797a3e17a9be227 |
| institution | OA Journals |
| issn | 1875-9572 |
| language | English |
| publishDate | 2015-10-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Pediatrics and Neonatology |
| spelling | doaj-art-d73f16eced3145af9797a3e17a9be2272025-08-20T02:04:01ZengElsevierPediatrics and Neonatology1875-95722015-10-0156528729310.1016/j.pedneo.2014.10.006Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug ResistanceShih-Hsiang ChenAsparaginase is one of the most important chemotherapeutic agents against pediatric acute lymphoblastic leukemia (ALL), the most common form of childhood cancer. The therapeutic efficacy (e.g., chemoresistance) and adverse effects of asparaginase (e.g., hypersensivity and pancreatitis) have been investigated over the past four decades. It was suggested early on that leukemic cells are resistant to asparaginase because of their increased asparagine synthetase activity. Afterward, other mechanisms associated with asparaginase resistance were reported. Not only leukemic cells but also patients themselves may play a role in causing asparaginase resistance, which has been associated with unfavorable outcome in children with ALL. This article will briefly review asparaginase therapy in children with ALL and comprehensively analyze recent reports on the potential mechanisms of asparaginase resistance.http://www.sciencedirect.com/science/article/pii/S1875957214001983acute lymphoblastic leukemiaasparaginasechemotherapychildrenresistance |
| spellingShingle | Shih-Hsiang Chen Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance Pediatrics and Neonatology acute lymphoblastic leukemia asparaginase chemotherapy children resistance |
| title | Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance |
| title_full | Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance |
| title_fullStr | Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance |
| title_full_unstemmed | Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance |
| title_short | Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance |
| title_sort | asparaginase therapy in pediatric acute lymphoblastic leukemia a focus on the mode of drug resistance |
| topic | acute lymphoblastic leukemia asparaginase chemotherapy children resistance |
| url | http://www.sciencedirect.com/science/article/pii/S1875957214001983 |
| work_keys_str_mv | AT shihhsiangchen asparaginasetherapyinpediatricacutelymphoblasticleukemiaafocusonthemodeofdrugresistance |